Tuesday, June 19, 2018
Create an account
In the Know
National Meeting Summaries
ESP Tool Kit III
ESP Patient Referral Tool
UDT Interactive Cases
Patient Education Series
Clinical Challenges in Migraine: The Role of Emerging Therapies in New Treatment Paradigms
Therapeutic Advances and Evolving Treatment Strategies: Novel Approaches to Migraine Management
Case Studies in Migraine
Targeting CGRP: Emerging Solutions in Migraine
Recognizing and Treating Breakthrough Pain: Aligning Our Treatment Approach
Targeting Breakthrough Pain: A Patient Case Report
Managing Breakthrough Pain Across the Provider Continuum
Clinical Dialogues in Pain - OIC
The Emerging Solutions in Pain Responsible Opioid Prescribing Series
Clinical Dialogues in Pain
Effective Strategies in Managing Breakthrough Pain
National Meeting Highlights
Virtual Grand Rounds
How to Talk to Your Patients About Opioid-induced Constipation: A Dialogue About New Advances
Navigating Pitfalls in OIC: A Patient-focused Strategy
Patient-Centered Approaches to Treatment of Migraine: Real-World Cases with Real-World Challenges
What key factors should be included in a treatment agreement?
Kenneth L. Kirsh, PhD
February 24, 2012
Dr. Kirsh discusses what key factors should be included in a treatment agreement.
What is opioid rotation? How is it done?
Mary Lynn McPherson, PharmD, BCPS,CPE
February 17, 2012
Dr. McPherson discusses what opioid rotation is and explains how it is done.
What critical educational points should be covered to teach safe use to the patient?
Lynn R. Webster, MD, FACPM, FASAM
February 10, 2012
Dr. Lynn Webster discusses what the critical educational points are that should be covered when teaching patients about safe use of their opioids.
What are some clues that my patients might be abusing their opioid medications?
John F. Peppin, DO, FACP
February 3, 2012
What is the safest way to dispose of unused opioids? Can I simply "flush" them down the drain?
Kathryn L. Hahn, PharmD, DAAPM, CPE
November 23, 2011
Should clinicians require UDT on only those patients who are exhibiting aberrant behaviors?
Howard A. Heit, MD, FACP, FASAM
November 11, 2011
Assess & Monitor
Dr. Heit discusses whether clinicians should require UDT on only those patients who are exhibiting aberrant behaviors.
How can I improve communication with a chronic pain patient during a brief follow-up visit?
Daniel B. Carr, MD, FABPM
November 4, 2011
Why should we use UDT in our pain practices?
Steven D. Passik, PhD
September 9, 2011
Assess & Monitor
Dr. Passik discusses why clinicians should incorporate UDT into their pain practice.
How can prescribers properly counsel patients on safe use and responsibilities of using opioids?
Perry G. Fine, MD
September 2, 2011
Dr. Fine discusses how prescribers can properly counsel patients on safe use and the responsibilities associated with opioid use.
How can we best assess the contributions that community-based pharmacists make to patient outcomes?
Scott Strassels, PharmD, PhD, BCPS
July 29, 2011
Dr. Strassels discusses how we can best assess the contributions that community-based pharmacists make to patient outcomes and if there is data to support this.
Page 5 of 5
Results 41 - 50 of 50
Worldwide, Inc. Links